Dispatch Biotherapeutics
Immunotherapy for Solid Tumors
Philadelphia, United States · Founded 2022 · $106.0M raised
- Headquarters
- Philadelphia
- Founded
- 2022
- Business Model
- B2B
- Website
- dispatchbio.com
- Total Funding
- $106.0M
- Last Round
- $100.0M Series AJul 2025
- Rounds
- 2
About
Dispatch Biotherapeutics (Dispatch Bio) is a clinical-stage immunotherapy company founded in 2022 with a bold purpose: to help create a world where all cancer patients can be cured. The company is engineering a universal treatment across solid tumors through its first-in-class Flare platform, which combines the precision of immunotherapy with a tumor-specific virus engineered to clear tumor cells. Co-founded by scientists from Stanford, UCSF, Penn, and Memorial Sloan Kettering, Dispatch operates R&D sites in Philadelphia and San Francisco and is backed by ARCH Venture Partners.
Summary
Dispatch Biotherapeutics is a Biotech company based in Philadelphia, United States, founded in 2022. It has raised $106.0M in total across 2 rounds, most recently a $100.0M Series A round in Jul 2025. Investors include Parker Institute for Cancer Immunotherapy, ARCH Venture Partners and Bristol Myers Squibb.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jul 2025
Sign up to see all 2 rounds
Seed through Series A — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...
Novel bicyclic peptides and drug conjugates for cancer
Clinical-stage biopharmaceutical company founded in 2015 developing best-in-class cancer therapeu...
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/dispatch-biotherapeutics"><img src="https://indexed.vc/api/badge/company/dispatch-biotherapeutics" alt="Dispatch Biotherapeutics on Indexed.vc" width="260" height="76" /></a>